Corrigendum to “A pilot study comparing treatments for severe attacks of neuromyelitis optica spectrum disorders: Intravenous methylprednisolone (IVMP) with add-on plasma exchange (PLEX) versus simultaneous ivmp and PLEX” [Multiple Sclerosis and Related Disorders (2020) 1;38:101506] (Multiple Sclerosis and Related Disorders (2020) 38, (S221103481930495X), (10.1016/j.msard.2019.101506))
Multiple Sclerosis and Related Disorders Vol.93 (2025)
Suggested Citation
Songthammawat T., Srisupa-Olan T., Siritho S., Kittisares K., Jitprapaikulsan J., Sathukitchai C., Prayoonwiwat N. Corrigendum to “A pilot study comparing treatments for severe attacks of neuromyelitis optica spectrum disorders: Intravenous methylprednisolone (IVMP) with add-on plasma exchange (PLEX) versus simultaneous ivmp and PLEX” [Multiple Sclerosis and Related Disorders (2020) 1;38:101506] (Multiple Sclerosis and Related Disorders (2020) 38, (S221103481930495X), (10.1016/j.msard.2019.101506)). Multiple Sclerosis and Related Disorders Vol.93 (2025). doi:10.1016/j.msard.2024.106233 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/102979
Title
Corrigendum to “A pilot study comparing treatments for severe attacks of neuromyelitis optica spectrum disorders: Intravenous methylprednisolone (IVMP) with add-on plasma exchange (PLEX) versus simultaneous ivmp and PLEX” [Multiple Sclerosis and Related Disorders (2020) 1;38:101506] (Multiple Sclerosis and Related Disorders (2020) 38, (S221103481930495X), (10.1016/j.msard.2019.101506))
The authors would like to thank the funding resource as below. Acknowledgments The authors are grateful for the funding resource. This research project is supported by Mahidol University.
